AstraZeneca Pharma India Q4 profit falls 34%; board recommends Rs 16/share dividend
AstraZeneca Pharma dividend: AstraZeneca Pharma India's board on Tuesday announced a dividend of Rs 16 per equity share for the financial year 2022-23.
AstraZeneca Pharma India on Tuesday reported a net profit of Rs 17.3 crore for the quarter ended March 2023, marking a decline of 37.4 per cent compared with the corresponding period a year ago. Its revenue came in at Rs 284.7 crore as against Rs 222 crore for the year-ago period, according to a regulatory filing.
AstraZeneca Pharma dividend
AstraZeneca Pharma India's board recommended a dividend of Rs 16 per equity share — an 800 per cent payout given the face value of Rs 2 per share.
AstraZeneca Pharma shares — traded on the bourses with the symbol ASTRAZEN — ended 2.4 per cent higher at Rs 3,332 apiece on BSE ahead of the earnings announcement.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
Traders' Diary: Buy, sell or hold strategy on Nykaa, SBI Life, Wipro, DMart, Bata, over a dozen other stocks today
India's 'activist' central bank to temper rupee, bond gains post index inclusion: JPMorgan's Jahangir Aziz
India Vs Australia LIVE Score, 3rd ODI Match Updates, IND VS AUS live Scorecard: Rohit Sharma's men eye clean sweep against struggling Aussies at Rajkot